Title : Ectopic Overexpression of PPARĪ³2 in the Heart Determines Differences in Hypertrophic Cardiomyopathy After Treatment With Different Thiazolidinediones in a Mouse Model of Diabetes.

Pub. Date : 2021

PMID : 34305596






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The clinical controversy of rosiglitazone as a hypoglycemic agent is potentially associated with heart failure, mainly due to its potent activation of peroxisome proliferator-activated receptor gamma (PPARgamma). Rosiglitazone peroxisome proliferator activated receptor gamma Mus musculus
2 The clinical controversy of rosiglitazone as a hypoglycemic agent is potentially associated with heart failure, mainly due to its potent activation of peroxisome proliferator-activated receptor gamma (PPARgamma). Rosiglitazone peroxisome proliferator activated receptor gamma Mus musculus
3 High-fat diet (HFD) induced obese mice, ob/ob mice and cardiomyocytes overexpressing PPARgamma2 were treated with CMHX008 or rosiglitazone. Rosiglitazone peroxisome proliferator activated receptor gamma Mus musculus